Prior studies using transient transfection assays in cultured avian and murine skeletal myotubes indicate that the proximal 2-kb segment of the 5' flanking region of the human myoglobin gene contains transcriptional control elements sufficient to direct muscle-specific and developmentally regulated expression of reporter genes. To examine the function of the human myoglobin gene promoter during development of skeletal and cardiac myocytes in the intact animal, a 2.0-kb myoglobin gene upstream fragment was fused to an Escherichia coli lacZ reporter gene and injected into fertilized mouse oocytes. 1-Galactosidase (13-gal) activity was detected selectively in cardiac and skeletal myocytes of fetal and adult transgenic mice. A distinctive spatial pattern of myoglobin promoter activity was observed in fetal hearts: (-gal staining was more pronounced within the left ventricular subendocardium than within the subepicardium and was essentially undetectable in the ventricular trabeculae or atria. Expression of endogenous myoglobin mRNA and protein, assessed by in situ hybridization and immunohistochemistry, demonstrated a similar spatial pattern. In contrast, hearts from adult transgenic mice demonstrated essentially homogeneous expression of 13-gal and of endogenous myoglobin mRNA and protein throughout the myocardium, including the trabeculae and atria. These data indicate that the 2.0-kb upstream region of the human myoglobin gene includes cis-acting regulatory elements sufficient to direct transgene expression during murine cardiac development that is myocyte-specific and responsive to positional cues in a similar manner to the endogenous myoglobin gene.
ABSTRACT
Prior studies using transient transfection assays in cultured avian and murine skeletal myotubes indicate that the proximal 2-kb segment of the 5' flanking region of the human myoglobin gene contains transcriptional control elements sufficient to direct muscle-specific and developmentally regulated expression of reporter genes. To examine the function of the human myoglobin gene promoter during development of skeletal and cardiac myocytes in the intact animal, a 2.0-kb myoglobin gene upstream fragment was fused to an Escherichia coli lacZ reporter gene and injected into fertilized mouse oocytes. 1-Galactosidase (13-gal) activity was detected selectively in cardiac and skeletal myocytes of fetal and adult transgenic mice. A distinctive spatial pattern of myoglobin promoter activity was observed in fetal hearts: (-gal staining was more pronounced within the left ventricular subendocardium than within the subepicardium and was essentially undetectable in the ventricular trabeculae or atria. Expression of endogenous myoglobin mRNA and protein, assessed by in situ hybridization and immunohistochemistry, demonstrated a similar spatial pattern. In contrast, hearts from adult transgenic mice demonstrated essentially homogeneous expression of 13-gal and of endogenous myoglobin mRNA and protein throughout the myocardium, including the trabeculae and atria. These data indicate that the 2.0-kb upstream region of the human myoglobin gene includes cis-acting regulatory elements sufficient to direct transgene expression during murine cardiac development that is myocyte-specific and responsive to positional cues in a similar manner to the endogenous myoglobin gene.
The discovery of the family of myogenic determination genes and the characterization of their protein products as components of heterooligomeric DNA-binding transcription factors have illuminated important features of the genetic control mechanisms that direct the development of skeletal myocytes (1) (2) (3) (4) (5) . However, much less progress has been made in elucidating cis-acting transcriptional control elements and the cognate binding factors that mediate the development of the related but distinct cell lineage that forms cardiomyocytes. Moreover, many of the important phenotypic properties of both skeletal and cardiac myocytes are not determined exclusively by developmental programs but are regulated by physiological and metabolic stimuli that match the biochemical and structural characteristics of myocytes to the demand for contractile work (6) (7) (8) (9) (10) (11) .
Myoglobin is a cytosolic hemoprotein that is expressed selectively in cardiac and skeletal myocytes, where it functions to facilitate diffusion of oxygen and to maintain mitochondrial respiration during heavy and sustained contractile work and in the rest-work transition (12) . Within fully differentiated myocytes, expression of myoglobin is exquisitely sensitive to changes in tonic contractile activity that increase the demand for ATP production via oxidative metabolism (13, 14) . We previously have explored the developmental regulation ofthe myoglobin gene in skeletal myotubes and have identified a muscle-specific enhancer element within the 5' flanking region of the human myoglobin gene (15) (16) (17) . The present study was undertaken as a step toward elucidation of transcriptional control mechanisms that regulate the expression of myoglobin during cardiac development.
MATERIALS AND METHODS
Plasmid Construction. A 2-kb segment of the 5' flanking region of the human myoglobin gene extending from position -2038 to +7 relative to the cap site was removed as a Pvu II fragment from a genomic clone originally isolated by Weller et al. (18) . This segment was subcloned into the HincII site of pBSM13+ (15) Pipes (pH 7.4) for 15 min at room temperature and stained overnight with 5-bromo-4-chloro-3-indolyl f3-D-galactoside (X-Gal) (21) . Tissues were dehydrated in ethanol and cleared with xylene and cedar wood oil. For microscopic analysis of transgene expression, tissues were embedded in paraffin, sectioned at a thickness of 3 ,um, and counterstained with nuclear fast red.
In Situ Hybridization. A 503-bp fragment (exon 3) of the murine myoglobin gene was prepared by use of the polymerase chain reaction. This fragment was subcloned into the EcoRI/Xba I sites of pGEM-3Z (Promega), and its identity was confirmed by DNA sequencing (22) . Radiolabeled antisense and sense probes were generated by in vitro transcription of linearized DNA templates using either phage T7 or SP6 RNA polymerase (Promega) in the presence of 35S-labeled UTP (1200 Ci/mmol, DuPont; 1 Ci = 37 GBq). Fetal and adult mouse hearts of strain FVB/N were fixed overnight at 4°C in 0.1 M phosphate-buffered saline/4% paraformaldehyde, pH 7.5. Tissues were dehydrated in ethanol, cleared with xylene, embedded in paraffin, sectioned at a thickness of 3 ,um, and mounted on aminoalkylsilanetreated slides. Hybridizations to radiolabeled probes were performed as described by Wilkinson et al. (23) with modifications described by Frohman et al. (24) .
Immunohistochemical Analysis. Tissue sections were prepared as described for in situ hybridization, deparaffmized, and incubated with rabbit anti-chicken myosin IgG antibody (gift of Woodring E. Wright, University of Texas Southwestern Medical Center, Dallas) or with goat anti-human myoglobin IgG antibody (Organon Teknika-Cappel). Both antibodies cross-react with their corresponding murine proteins (25) . Primary antibodies were detected by using an immunoperoxidase procedure (Vectastain ABC kit; Vector Laboratories). Sections were counterstained with Harris hematoxylin. RESULTS Southern blot hybridization analysis (not shown) revealed that, among the 12 offspring tested at a gestational age of 18. Similarly, among 15 offspring tested at a postnatal age of 28 days, transgene integration had occurred in 4 animals. Variations in intensity and size of bands observed in the Southern blot reflected differences in copy number and orientation of the transgene inserts among these animals and indicated independent chromosomal integration events. Endogenous ,3-gal activity was evident in small intestine and kidney of all animals (not shown) irrespective of the presence of the transgene, as described previously (26) . In 2 of the 3 fetal transgenic animals and in 2 of the 4 adult transgenic animals, (3-gal activity was expressed within the hearts. In these animals transgene expression also was detected in skeletal muscle, but not in brain, liver, lung, or spleen.
Microscopic analysis of (3-gal expression in the fetal heart is shown in Fig. 1 . A similar pattern of staining was observed in both transgene-positive fetal mice that expressed 3-gal activity. Transgene expression was limited to cardiomyocytes and was absent in nonmyocytes within the ventricular wall and valves. Of note, 3-gal activity within the left ventricular wall was more prominent in the subendocardium than in the subepicardial regions. In addition, the ventricular trabeculae and atria were devoid of(-gal activity. Analysis of endogenous myoglobin mRNA and protein by in situ hybridization and immunohistochemistry, respectively, revealed a similar spatial pattern at this developmental stage (Figs. 2 and  3 ). In contrast, other muscle-specific genes, such as that encoding cytochrome oxidase subunit VIa (heart isogene), exhibited uniform mRNA expression in atria and ventricles and in the inner and outer regions of the left ventricular wall (data not shown). Likewise, at the protein level, an antimyosin antibody showed identical reactivity in all myocardial regions (data not shown).
The spatial gradients of myoglobin promoter activity in fetal hearts appear to be a transient feature of cardiac development, since the distribution of 3-gal activity in hearts of adult transgenic mice was similar in subepicardial and subendocardial regions of the left ventricle (Fig. 4) . In addition, (3-gal activity was readily detected in the atria and trabeculae. Expression ofendogenous myoglobin mRNA and protein likewise was similar within all regions of the adult mouse heart (Figs. 5 and 6, respectively).
DISCUSSION
A principal finding of this study is that the immediate upstream region (2 kb) ofthe human myoglobin gene includes cis-acting regulatory elements sufficient to localize expression of a heterologous reporter gene to cardiac and skeletal myocytes during prenatal development of the mouse. A second major finding is that the 2.0-kb fragment also includes regulatory elements sufficient to confer spatially graded expression of the transgene in fetal hearts in a manner similar to the endogenous myoglobin gene.
With respect to skeletal muscle development, these results confirm the conclusions drawn from transient transfection assays of primary cultures of skeletal myotubes derived from chicken embryos (15) . This region of the human myoglobin gene contains proximal promoter elements (TATA) and several sequence motifs shared among other genes that are expressed in a muscle-specific manner. Two E box motifs that are likely to comprise binding sites for the members of the basic helix-loop-helix family of myogenic determination genes (27) , a putative myocyte-enhancing factor 2 motif (28, 29) , and a CCAC motif (30) are present within the 2.0-kb upstream region of the human myoglobin gene (15) (16) (17) . We have employed fine-structure mutational analysis of these elements in transient transfection assays of cultured myotubes to define the relative contributions of these elements to transcriptional activation during skeletal muscle differentiation (15) (16) (17) . The Although a number of endogenous genes manifest a changing spatial pattern of expression during early embryogenesis of cardiac and skeletal muscle (31, 32) , the regional heterogeneity in activity of the myoglobin promoter that we observed in the heart late in murine gestation was unanticipated. It is unlikely that this pattern is due to inhomogeneity of fixation because 83-gal activity in the thicker walls of adult ventricles was essentially uniform in subepicardial and subendocardial regions. Donoghue et al. (33) 
